MMP12 and neoplasm: MMP12, predominantly engaged in extracellular matrix degradation and vascular reorganization, may indicate that elevated expression compromises effective vascular occlusion by TACE embolic materials in these patients’ tumor microenvironments, diminishing blood supply reduction efficacy while simultaneously augmenting tumor cell capacity for drug-resistant metastasis through matrix infiltration, collectively attenuating therapeutic outcomes.